Coronavirus Vaccine
-
Moderna asks regulators to expand its vaccine's use to 12-17 age group
World | May 26, 2021, 08:03 AM ISTThe Cambridge, Massachusetts, company said that the vaccine-induced immune responses among children were comparable to those seen in a study of adults last year, a finding that could clear the way for a second shot for use in adolescents after Pfizer-BioNTech
-
Gurugram to hold vaccination camp for differently-abled people
India | May 26, 2021, 06:39 AM ISTAccording to the health officials, the drive will begin at 11 a.m. and 100 free slots will be available without any registration. The vaccine will be administered on a first come first serve basis.
-
Moderna says its COVID-19 shot works in kids as young as 12
World | May 25, 2021, 06:41 PM ISTModerna said Tuesday its COVID-19 vaccine strongly protects kids as young as 12, a step that could put the shot on track to become the second option for that age group in the U.S.
-
14 days' stock of Covishield in Delhi for 45+; vaccination halted for 18-44 group
India | May 25, 2021, 09:30 AM ISTAAP MLA Atishi Marlena has informed that Delhi on Monday received nearly 1.5 lakh doses of Covishield for the 45 plus age group.
-
Covid-19: India vaccinates over 15.30 lakh people in single day, Watch report
News | May 24, 2021, 09:16 PM ISTOver 15 lakh people were vaccinated against Covid-19 in India on May 22. The government has revised the gap between the two doses for Covishield,to 12-16 weeks. However, the interval for the second dose of Bharat Biotech's Covaxin remains unchanged.
-
Over one crore vaccine doses administered in 18-44 age group
India | May 24, 2021, 03:32 PM ISTIndia has administered more than one crore vaccine doses in the 18-44 age group, the Union Health Ministry said on Monday.
-
Roche's Covid antibody cocktail launched in India for treatment of mild to moderate cases
India | May 24, 2021, 03:59 PM ISTRoche's Antibody Cocktail is now available in India at Rs 59,750 per dose for the treatment of mild to moderate Covid patients.
-
Over 1 crore in 18-44 age group vaccinated: Health Ministry
India | May 24, 2021, 01:03 PM ISTAccording to the health ministry, a total of 19,60,51,962 vaccine doses have been administered through 28,16,725 sessions, as per the provisional report till 7 am today.
-
UP: CM Yogi Adityanath plans to vaccinate all parents ahead of third wave
India | May 24, 2021, 11:26 AM ISTFrom June 1, people in the age group of 18 to 44 will be vaccinated in all districts. The chief minister said that 10.50 lakh people in the age group of 18 to 44 have been vaccinated in the state.
-
UP: Vaccination of people between 18-44 age to be expanded to all district headquarters from June 1
India | May 24, 2021, 06:26 AM ISTOn May 10, the vaccination drive was expanded to 17 district headquarters having municipal corporations and Gautam Buddh Nagar district. In the third phase, the number of districts was increased to 23, he added.
-
Covaxin trials on children likely from next month
India | May 23, 2021, 08:14 PM ISTBharat Biotech may commence paediatric trials of its Covid-19 vaccine Covaxin from June, a senior company official said. The vaccine maker has already received permission to carry out trials on children aged 2-18 years.
-
Vaccine drive to get faster after adequate supply starts from June: Maharashtra CM
India | May 23, 2021, 03:00 PM ISTThe CM said "unpleasant decisions" like lockdown had to be taken to contain the outbreak and asked people to get treated immediately if they are experiencing COVID-19 like symptoms.
-
Samsung Biologics signs vaccine production deal with Moderna
World | May 23, 2021, 10:56 AM ISTUnder the agreement, the biotech unit of Samsung Group will provide the US drugmaker with contract manufacturing organization (CMO) services for its mRNA vaccine. It means that some of the Moderna vaccine would be produced in South Korea.
-
Oxford/AstraZeneca vaccine 80 per cent effective against B1.617.2 variant: UK study
World | May 22, 2021, 07:06 PM ISTTwo doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of COVID-19, first discovered in India, a new UK government study has reportedly found.
-
Cumulative number of COVID-19 vaccine doses administered in India surpasses 19.32 crore: Govt
India | May 21, 2021, 11:35 PM ISTThe cumulative number of COVID-19 vaccine doses administered in the country stands at 19,32,97,222, according to the provisional report updated till 8 pm.
-
Delay in second shot of Pfizer vaccine boosts immunity in elderly by over 3 times: Study
India | May 21, 2021, 07:50 PM ISTDelay in giving second dose of the Pfizer COVID-19 vaccine by 12 weeks increases antibody response in older people by three-and-a-half times compared to those who receive it at a three-week interval, according to a study conducted in the UK.
-
Govt exploring possibility of Covaxin production outside India
India | May 21, 2021, 06:12 PM ISTTo address the shortage of COVID-19 jabs in the country, the government is exploring the possibility of boosting production of vaccines, including identifying manufacturing sites for indigenously developed Covaxin outside India, sources said.
-
2 Oxford/AstraZeneca vaccine doses 85-90 per cent effective, real-world study finds
World | May 21, 2021, 07:24 PM ISTTwo doses of the Oxford/AstraZeneca vaccine have shown to prevent around 85 to 90 per cent of symptomatic COVID-19 infections, the first real-world data from Public Health England (PHE) has found.
-
Delhi runs out of Covid vaccine for 18-44 age group, over 150 centres closed
India | May 21, 2021, 12:39 PM ISTAbout 150 Covid vaccination sites have been shut in Delhi from today due to shortage of vaccine.
-
Collect data related to Covid infection among children: PM Modi tells officials
India | May 20, 2021, 02:20 PM ISTPrime Minister Narendra Modi has cautioned against Covid vaccine wastage, saying even single dose going waste denies someone protection shield.